SK66799A3 - N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application - Google Patents

N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application Download PDF

Info

Publication number
SK66799A3
SK66799A3 SK667-99A SK66799A SK66799A3 SK 66799 A3 SK66799 A3 SK 66799A3 SK 66799 A SK66799 A SK 66799A SK 66799 A3 SK66799 A3 SK 66799A3
Authority
SK
Slovakia
Prior art keywords
group
formula
compound
carbon atoms
straight
Prior art date
Application number
SK667-99A
Other languages
English (en)
Slovak (sk)
Inventor
Jean-Michel Altenburger
Gilbert Lassalle
Valerie Martin
Daniel Galtier
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of SK66799A3 publication Critical patent/SK66799A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68Halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK667-99A 1996-11-22 1997-11-19 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application SK66799A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614309A FR2756285B1 (fr) 1996-11-22 1996-11-22 Derives de n-(imidazolylbutyle)benzenesulfonamide, leur preparation et leur application en therapeutique
PCT/FR1997/002079 WO1998022443A1 (fr) 1996-11-22 1997-11-19 Derives de n-(imidazolylbutyle) benzenesulfonamide ayant une activite antithrombotique

Publications (1)

Publication Number Publication Date
SK66799A3 true SK66799A3 (en) 2000-02-14

Family

ID=9497920

Family Applications (1)

Application Number Title Priority Date Filing Date
SK667-99A SK66799A3 (en) 1996-11-22 1997-11-19 N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application

Country Status (20)

Country Link
EP (1) EP0946517A1 (xx)
JP (1) JP2001504128A (xx)
KR (1) KR20000069063A (xx)
CN (1) CN1238765A (xx)
AR (1) AR009627A1 (xx)
AU (1) AU5226498A (xx)
BG (1) BG103414A (xx)
BR (1) BR9713291A (xx)
CA (1) CA2270478A1 (xx)
CO (1) CO4910158A1 (xx)
CZ (1) CZ178299A3 (xx)
EE (1) EE9900201A (xx)
FR (1) FR2756285B1 (xx)
HU (1) HUP9904599A2 (xx)
IL (1) IL129546A0 (xx)
NO (1) NO992436L (xx)
SK (1) SK66799A3 (xx)
TR (1) TR199901143T2 (xx)
WO (1) WO1998022443A1 (xx)
ZA (1) ZA9710515B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2783521B1 (fr) * 1998-09-18 2002-04-26 Synthelabo Derives de n-(arginyl) benzenesulfonamide, leur preparation et leur application en therapeutique
FR2806722B1 (fr) * 2000-03-23 2002-05-17 Sanofi Synthelabo Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
CN107207403A (zh) 2014-09-29 2017-09-26 塞尔利克斯生物私人有限公司 用于治疗多发性硬化的组合物和方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2689130B1 (fr) * 1992-03-30 1994-05-27 Synthelabo Derives de 1-[2 (arylsulfonylamino)ethyl-1-oxo] piperidine, leur preparation et leur application en therapeutique.
FR2710066B1 (fr) * 1993-09-14 1995-10-20 Synthelabo Dérivés de 1-[2-amino-5-[1-(triphénylméthyl-1H-imidazol-4-yl]-1-oxopentyl]piperidine, leur préparation et leur utilisation comme intermédiaires de synthèse.
FR2727410B1 (fr) * 1994-11-25 1996-12-20 Synthelabo Chlorures de sulfonyles, leur preparation et leur utilisation comme intermediaires de synthese
FR2728570B1 (fr) * 1994-12-23 1997-04-11 Synthelabo Derives de 1-oxo-2-(phenylsulfonylamino)pentylpiperidine, leur preparation et leur application en therapeutique
DE19548797A1 (de) * 1995-12-27 1997-07-03 Thomae Gmbh Dr K Substituierte 2-Amino-imidazole, ihre Herstellung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
AR009627A1 (es) 2000-04-26
JP2001504128A (ja) 2001-03-27
NO992436D0 (no) 1999-05-20
AU5226498A (en) 1998-06-10
CZ178299A3 (cs) 1999-08-11
BR9713291A (pt) 1999-10-26
FR2756285B1 (fr) 1998-12-18
EE9900201A (et) 1999-12-15
CA2270478A1 (en) 1998-05-28
CO4910158A1 (es) 2000-04-24
ZA9710515B (en) 1998-06-10
FR2756285A1 (fr) 1998-05-29
KR20000069063A (ko) 2000-11-25
WO1998022443A1 (fr) 1998-05-28
TR199901143T2 (xx) 1999-08-23
CN1238765A (zh) 1999-12-15
EP0946517A1 (fr) 1999-10-06
IL129546A0 (en) 2000-02-29
HUP9904599A2 (hu) 2000-06-28
BG103414A (en) 2000-01-31
NO992436L (no) 1999-07-22

Similar Documents

Publication Publication Date Title
CA2856831C (en) Substituted benzimidazoles and benzopyrazoles as ccr(4) antagonists
JP4093859B2 (ja) 抗アレルギー剤としてのピペリジン化合物
EP1076055B1 (en) 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
CA2722811C (en) Pyrazole compounds as ccr1 antagonists
ES2264994T3 (es) Compuestos heterociclilalquilindol o -azaindol como ligandos de 5-hidroxitriptamina-6.
CZ20023777A3 (cs) Farmaceuticky aktivní piperidinové deriváty, zvláště jako modulátory receptoru chemokinu
EA019192B1 (ru) Пиперидинильные производные в качестве модуляторов активности хемокинового рецептора
SK17312001A3 (sk) Inhibítory metaloproteázy
WO2001021615A1 (en) Benzimidazole derivatives
BRPI0820171B1 (pt) Compostos de carboxamida, sulfonamida e amina para distúrbiosmetabólicos, composição farmacêutica, e, uso dos mesmos
BR112016011755B1 (pt) Derivado de ureia ou sal farmacologicamente aceitável do mesmo, seu uso e composição farmacêutica que os compreende
JP2001039974A (ja) Orl1−レセプターアゴニストとしての2−ベンズイミダゾリルアミン化合物
CA2730116A1 (en) Pyrrolidinyl and piperidinyl compounds useful as nhe-1 inhibitors
JP5067364B2 (ja) アシルアミノピペリジン化合物
KR20090031605A (ko) 신규한 피리딘 유사체
JP2009503048A (ja) 尿路機能障害を治療するためのmc4r作動薬
EA015123B1 (ru) ПРОИЗВОДНЫЕ ПИРАЗОЛИЗОХИНОЛИНМОЧЕВИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ p38 КИНАЗЫ
HU221811B1 (hu) N-acilezett-piperidin-származékok, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
US5317025A (en) Piperidinylthioindole derivatives, their methods of preparation and pharmaceutical compositions in which they are present, useful especially as analgesics
SK66799A3 (en) N-(imidazolylbutyl) benzenesulphonamide derivatives, their preparation and therapeutic application
BR112018008204B1 (pt) Composto, composição farmacêutica, e, método para tratamento de distúrbios associados com irregularidades da transmissão de sinal glutamatérgico e de distúrbios do sistema nervoso central
SK286687B6 (sk) Sulfónamidy, spôsob ich výroby, medziprodukty, liečivo a farmaceutická kompozícia s ich obsahom
JP2001122784A (ja) 1−[(1−置換−4−ピペリジニル)メチル]−4−ピペリジン誘導体からなる医薬
KR20010031724A (ko) 페닐-알킬-이미다졸 유형의 h₃ 수용체 리간드
EP0661273B1 (en) Indane derivatives and processes for preparing the same